Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Bladder cancer
Trial Type:  Treatment
Treatment/Intervention:  vaccine therapy
Results 1-4 of 4 for your search:
Start Over
BCG Solution with or without PANVAC in Treating Patients with Localized Bladder Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: Over 18
Trial IDs: 14-C-0036, NCI-2014-00115, 1310-1269, 140036, RD-13-X-04, 9539, NCT02015104
Vaccine Therapy in Treating Patients with HER2-Positive Solid Tumors
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 13-C-0016, NCI-2013-01564, 130016, P12990, NCT01730118
A Personalized Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: NT-001, NCI-2016-01653, NCT02897765
Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients with Muscle-Invasive Bladder Cancer Undergoing Surgery
Status: Not yet active
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: MC1452, NCI-2016-01517, NCT02944357
Start Over